GNMLF
Price
$1.17
Change
+$0.08 (+7.34%)
Updated
Jul 29 closing price
Capitalization
1.17B
LVRLF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
6.46M
58 days until earnings call
Interact to see
Advertisement

GNMLF vs LVRLF

Header iconGNMLF vs LVRLF Comparison
Open Charts GNMLF vs LVRLFBanner chart's image
Genomma Lab International SAB DE CV
Price$1.17
Change+$0.08 (+7.34%)
Volume$100
Capitalization1.17B
CordovaCann
Price$0.06
Change-$0.00 (-0.00%)
Volume$4.7K
Capitalization6.46M
GNMLF vs LVRLF Comparison Chart in %
Loading...
GNMLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LVRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNMLF vs. LVRLF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNMLF is a Hold and LVRLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (GNMLF: $1.17 vs. LVRLF: $0.06)
Brand notoriety: GNMLF and LVRLF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GNMLF: 68% vs. LVRLF: 29%
Market capitalization -- GNMLF: $1.17B vs. LVRLF: $6.46M
GNMLF [@Pharmaceuticals: Generic] is valued at $1.17B. LVRLF’s [@Pharmaceuticals: Generic] market capitalization is $6.46M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNMLF’s FA Score shows that 1 FA rating(s) are green whileLVRLF’s FA Score has 0 green FA rating(s).

  • GNMLF’s FA Score: 1 green, 4 red.
  • LVRLF’s FA Score: 0 green, 5 red.
According to our system of comparison, GNMLF is a better buy in the long-term than LVRLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNMLF’s TA Score shows that 2 TA indicator(s) are bullish while LVRLF’s TA Score has 4 bullish TA indicator(s).

  • GNMLF’s TA Score: 2 bullish, 1 bearish.
  • LVRLF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, LVRLF is a better buy in the short-term than GNMLF.

Price Growth

GNMLF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while LVRLF (@Pharmaceuticals: Generic) price change was -1.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

LVRLF is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNMLF($1.17B) has a higher market cap than LVRLF($6.46M). LVRLF YTD gains are higher at: 47.125 vs. GNMLF (-7.874).
GNMLFLVRLFGNMLF / LVRLF
Capitalization1.17B6.46M18,059%
EBITDA4.02BN/A-
Gain YTD-7.87447.125-17%
P/E Ratio11.55N/A-
Revenue18.8BN/A-
Total Cash2.59BN/A-
Total Debt7.2BN/A-
FUNDAMENTALS RATINGS
GNMLF vs LVRLF: Fundamental Ratings
GNMLF
LVRLF
OUTLOOK RATING
1..100
3727
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
97
Overvalued
PROFIT vs RISK RATING
1..100
82100
SMR RATING
1..100
61100
PRICE GROWTH RATING
1..100
5861
P/E GROWTH RATING
1..100
86100
SEASONALITY SCORE
1..100
55n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GNMLF's Valuation (10) in the null industry is significantly better than the same rating for LVRLF (97). This means that GNMLF’s stock grew significantly faster than LVRLF’s over the last 12 months.

GNMLF's Profit vs Risk Rating (82) in the null industry is in the same range as LVRLF (100). This means that GNMLF’s stock grew similarly to LVRLF’s over the last 12 months.

GNMLF's SMR Rating (61) in the null industry is somewhat better than the same rating for LVRLF (100). This means that GNMLF’s stock grew somewhat faster than LVRLF’s over the last 12 months.

GNMLF's Price Growth Rating (58) in the null industry is in the same range as LVRLF (61). This means that GNMLF’s stock grew similarly to LVRLF’s over the last 12 months.

GNMLF's P/E Growth Rating (86) in the null industry is in the same range as LVRLF (100). This means that GNMLF’s stock grew similarly to LVRLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNMLFLVRLF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
27%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
17%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
25%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
23%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
32%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
GNMLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LVRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDTX2.940.07
+2.44%
Black Diamond Therapeutics
AVAL3.310.01
+0.30%
Grupo Aval Acciones Y Valores SA
EQT51.60-0.20
-0.39%
EQT Corp
IVA5.57-0.03
-0.54%
Inventiva SA
FCUV2.16-0.02
-1.10%
Focus Universal

GNMLF and

Correlation & Price change

A.I.dvisor tells us that GNMLF and AQST have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNMLF and AQST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNMLF
1D Price
Change %
GNMLF100%
N/A
AQST - GNMLF
21%
Poorly correlated
+7.11%
LVRLF - GNMLF
20%
Poorly correlated
+1.96%
VEXTF - GNMLF
20%
Poorly correlated
+13.89%

LVRLF and

Correlation & Price change

A.I.dvisor tells us that LVRLF and GNMLF have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LVRLF and GNMLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVRLF
1D Price
Change %
LVRLF100%
+1.96%
GNMLF - LVRLF
20%
Poorly correlated
N/A
MCUJF - LVRLF
14%
Poorly correlated
N/A
IPSEY - LVRLF
9%
Poorly correlated
+3.39%
MEDIF - LVRLF
8%
Poorly correlated
-1.26%
KSPHF - LVRLF
5%
Poorly correlated
N/A
More